Total medical devices industry venture financing deals in May 2019 worth $876.56m were announced in the US, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the code below into your website to display the chart.
The value marked an increase of 67.5% over the previous month and a rise of 62.5% when compared with the last 12-month average of $539.41m.
The US held a 67.3% share of the global medical devices industry venture financing deal value that totalled $1.3bn in May 2019.
In terms of deal activity, the US recorded 64 deals during May 2019, marking an increase of 10.3% over the previous month and a rise of 23.1% over the 12-month average.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The US medical devices industry venture financing deals in May 2019: Top deals
The top five medical devices industry venture financing deals accounted for 35.9% of the overall value during May 2019.
The combined value of the top five medical devices industry venture financing deals stood at $315m, against the overall value of $876.56m recorded for the month. The top announced medical devices industry venture financing deal tracked by GlobalData in May 2019 was Biomatics Capital Partners, BlueCross BlueShield Venture Partners, Camden Partners Holdings, Casdin Capital, Cowin Venture Capital, Exact Sciences, Gamma3, Section 32, Invus Group and Third Rock Ventures’ $110m venture financing of Thrive Earlier Detection.
In second place was the $60m venture financing of ArcherDx by Boulder Ventures, Longwood Fund Management, PBM Capital Group, Peierls Foundation and Perceptive Advisors and in third place was Action Potential Venture Capital, Baird Capital Partners, dRx Capital, GV Management Co, Johnson & Johnson Innovation – JJDC, LifeSci Venture Partners, LSV Capital Management, Lux Capital, Novartis Venture Fund and Triventures’ $50m venture financing of Cala Health.
The $50m venture financing of Groop Internet Platform by Compound Ventures, Norwest Venture Partners, Qumra Capital, Revolution Growth and Spark Capital and Accelmed Growth Partners’ venture financing of EndoGastric Solutions for $45m held fourth and fifth positions, respectively.
Verdict deals analysis methodology
This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.
GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.
More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.